Suncare Traders Limited Confirms No Unutilized Proceeds from Public or Preferential Issues as on March 31, 2026

1 min read     Updated on 07 May 2026, 10:43 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Suncare Traders Limited filed a disclosure with BSE Limited on May 07, 2026, under Regulation 32(1) of SEBI (LODR) Regulations, 2015, confirming no unutilized funds remain as on March 31, 2026, from any public issue, rights issue, preferential issue, or QIP. The filing was made pursuant to SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019. Since no unutilized proceeds exist, the company confirmed that Annexure-A is not required to be submitted. The disclosure was signed by Wholetime Director Harshad Rathod.

powered bylight_fuzz_icon
39719608

*this image is generated using AI for illustrative purposes only.

Suncare Traders Limited has filed a regulatory disclosure with BSE Limited under Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, dated May 07, 2026. The filing confirms that the company has no funds remaining unutilized as on March 31, 2026, or as on the date of the disclosure, from any capital-raising exercise undertaken in the past.

Regulatory Background

The disclosure was made in compliance with SEBI Circular CIR/CFD/CMD1/162/2019 dated December 24, 2019, which mandates listed companies to submit periodic statements on any deviation or variation in the utilization of proceeds raised through public issues, rights issues, preferential issues, or qualified institutional placements (QIPs). Regulation 32(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 forms the overarching framework governing such disclosures.

Key Disclosure Details

The following table summarizes the key parameters of the regulatory filing:

Parameter: Details
Filing Date: May 07, 2026
Regulation: Regulation 32(1), SEBI (LODR) Regulations, 2015
SEBI Circular Reference: CIR/CFD/CMD1/162/2019 dated December 24, 2019
Reporting Period: As on March 31, 2026
Unutilized Funds: Nil
Annexure-A Required: No
Signatory: Harshad Rathod, Wholetime Director

Company's Statement

Suncare Traders Limited explicitly stated that the company does not have any funds remaining unutilized as on March 31, 2026, or as on date, out of the proceeds of public issue, rights issue, preferential issue, qualified institutional placement (QIP), etc., if any undertaken by it at any time in the past. In view of this position, the company has confirmed that no information is required to be provided by way of Annexure-A pursuant to the said regulation or circular.

The disclosure was digitally signed by Harshad Rathod, Wholetime Director, on May 07, 2026, and submitted to the Listing Department of BSE Limited, P J Tower, Dalal Street, Mumbai – 400001.

Historical Stock Returns for Suncare Traders

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+20.45%

Is Suncare Traders Limited planning any new capital-raising exercises such as a rights issue or QIP in the near future to fund potential business expansion?

How has the complete utilization of previously raised funds impacted Suncare Traders' financial performance and growth metrics over the past fiscal year?

What strategic investments or projects were funded through Suncare Traders' past capital-raising activities, and have they delivered the projected returns?

Suncare Traders Reports Audited Standalone Financial Results for Year Ended March 31, 2026

4 min read     Updated on 07 May 2026, 10:31 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Suncare Traders Limited reported audited standalone financial results for the quarter and year ended March 31, 2026, with annual net profit rising to ₹66.21 lacs from ₹59.42 lacs in FY25, despite a decline in total income from operations to ₹251.74 lacs from ₹534.85 lacs. The Q4 FY26 quarter recorded a net loss of ₹(131.87) lacs. Total assets grew to ₹4,791.48 lacs, and cash and cash equivalents closed at ₹36.10 lacs, with an unmodified audit opinion issued by M/s. Goenka Mehta & Associates.

powered bylight_fuzz_icon
39717233

*this image is generated using AI for illustrative purposes only.

Suncare Traders Limited approved its audited standalone financial results for the quarter and year ended March 31, 2026, at a Board of Directors meeting held on May 7, 2026. The board meeting commenced at 05:10 PM and concluded at 05:40 PM. The statutory auditors, M/s. Goenka Mehta & Associates, Chartered Accountants (FRN: 129445W), issued an unmodified opinion on the financial results, prepared in accordance with Indian Accounting Standards under the Companies Act, 2013, and in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Annual Financial Performance

For the full year ended March 31, 2026, Suncare Traders reported total income from operations of ₹251.74 lacs, compared to ₹534.85 lacs in the previous year. The company recorded a net profit after tax of ₹66.21 lacs for FY26, against ₹59.42 lacs in FY25. The following table summarises the key annual financial metrics (figures in Rs. in lacs):

Metric: Year Ended 31-Mar-26 (Audited) Year Ended 31-Mar-25 (Audited)
Other Operating Income: 251.74 534.85
Total Income from Operations (Net): 251.74 534.85
Employee Benefit Expense: 11.55 11.96
Finance Costs: 30.17 33.76
Depreciation and Amortization: - 0.39
Other Expenses: 140.43 409.31
Total Expenses: 182.15 455.42
Profit/(Loss) Before Tax: 69.58 79.43
Tax Expense: 3.38 20.01
Net Profit/(Loss) After Tax: 66.21 59.42
Total Comprehensive Income: 66.21 59.42
Basic EPS (₹2/- each, not annualised): 0.03 0.02
Diluted EPS (₹2/- each, not annualised): 0.03 0.02

Quarterly Financial Performance

For the quarter ended March 31, 2026, the company reported total income from operations of ₹33.98 lacs and a net loss after tax of ₹(131.87) lacs. This compares to a net profit of ₹28.33 lacs in the quarter ended December 31, 2025, and a net loss of ₹(20.05) lacs in the quarter ended March 31, 2025. The quarterly results are presented below (figures in Rs. in lacs):

Metric: Q4 FY26 (31-Mar-26, Audited) Q3 FY26 (31-Dec-25, Unaudited) Q4 FY25 (31-Mar-25, Audited)
Other Operating Income: 33.98 29.97 63.80
Total Income from Operations (Net): 33.98 29.97 63.80
Employee Benefit Expense: 9.37 0.57 10.49
Finance Costs: 30.03 - 8.07
Other Expenses: 123.08 1.07 89.39
Total Expenses: 162.48 1.64 108.25
Profit/(Loss) Before Tax: (128.49) 28.33 (44.45)
Tax Expense: 3.38 - (24.40)
Net Profit/(Loss) After Tax: (131.87) 28.33 (20.05)
Basic EPS (₹2/- each, not annualised): (0.05) 0.01 (0.01)
Diluted EPS (₹2/- each, not annualised): (0.05) 0.01 (0.01)

Balance Sheet Highlights

As at March 31, 2026, Suncare Traders reported total assets of ₹4,791.48 lacs, compared to ₹4,707.17 lacs as at March 31, 2025. Non-current assets stood at ₹4,488.50 lacs, while current assets were ₹302.99 lacs. The equity share capital remained unchanged at ₹5,100.00 lacs, with other equity at ₹(1,003.87) lacs, resulting in total shareholders' funds of ₹4,096.13 lacs. Key balance sheet figures are presented below (figures in Rs. in Lakhs):

Particulars: As at 31-Mar-26 (Audited) As at 31-Mar-25 (Audited)
Non-Current Assets: 4,488.50 4,553.23
Current Assets: 302.99 153.94
Total Assets: 4,791.48 4,707.17
Equity Share Capital: 5,100.00 5,100.00
Other Equity: (1,003.87) (1,070.08)
Shareholders' Funds: 4,096.13 4,029.92
Non-Current Liabilities: 626.81 597.54
Current Liabilities: 68.55 79.71
Total Equity and Liabilities: 4,791.48 4,707.17

Cash Flow Summary

For the year ended March 31, 2026, the company reported net cash outflow from operating activities of ₹(297.80) lacs, compared to ₹(328.40) lacs in the previous year. Net cash inflow from investing activities stood at ₹314.19 lacs, against ₹250.26 lacs in the previous year. Cash outflow from financing activities was ₹(0.90) lacs, compared to ₹(18.11) lacs in the previous year. As a result, cash and cash equivalents increased from an opening balance of ₹20.61 lacs to a closing balance of ₹36.10 lacs as at March 31, 2026. The cash flow statement has been prepared under the indirect method as set out in Ind AS-7. Key cash flow figures are presented below (figures in Rs. in lacs):

Particulars: Year Ended 31-Mar-26 Year Ended 31-Mar-25
Net Cash Flow from Operating Activities: (297.80) (328.40)
Net Cash Flow from Investing Activities: 314.19 250.26
Net Cash Flow from Financing Activities: (0.90) (18.11)
Cash and Cash Equivalents (Opening Balance): 20.61 116.86
Cash and Cash Equivalents (Closing Balance): 36.10 20.61

Auditor's Report and Compliance

M/s. Goenka Mehta & Associates, Chartered Accountants (FRN: 129445W), conducted the audit in accordance with the Standards on Auditing specified under Section 143(10) of the Companies Act, 2013. The auditors expressed an unmodified opinion, stating that the standalone financial results give a true and fair view in conformity with the applicable Indian Accounting Standards and Regulation 33 of the SEBI (LODR) Regulations, 2015. The financial results were reviewed by the Audit Committee and approved by the Board of Directors at the meeting held on May 7, 2026. The company operates in a single segment, and accordingly, no separate segment results have been disclosed.

Historical Stock Returns for Suncare Traders

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%+20.45%

What strategic initiatives is Suncare Traders planning to reverse the ~53% decline in operating revenue from FY25 to FY26 and restore top-line growth?

Given the significant Q4 FY26 net loss of ₹131.87 lacs driven largely by a spike in 'Other Expenses,' what one-time or recurring charges contributed to this, and could similar expenses recur in FY27?

With negative other equity of ₹(1,003.87) lacs and persistent operating cash outflows, how does Suncare Traders plan to address its capital adequacy and long-term solvency concerns?

More News on Suncare Traders

1 Year Returns:0.00%